Skin involvement in systemic sclerosis

Rheumatology (United Kingdom)

Volumn 47, Issue SUPPL. 5, 2008, Pages v44-v45

  Czirják, Laszlo ^a   Foeldvari, I ^b   Muller Ladner U ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Allgemeines Krankenhaus Eilbek   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Atrophy; Durometer; Instrument; Outcome; Rodnan skin score; Scleroderma; Skin; Systemic sclerosis; Ultrasound

Indexed keywords

ANALYTIC METHOD; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; DISABILITY; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RODMAN SKIN SCORE; SCORING SYSTEM; SKIN ATROPHY; SKIN DISEASE; SKIN EXAMINATION; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; BIOMECHANICS; HARDNESS; HOSPITALIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATHOLOGY; REVIEW; SKIN;

BIOMECHANICS; HARDNESS; HUMANS; MAGNETIC RESONANCE IMAGING; PAIN MEASUREMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 65849335478     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken309     Document Type: Conference Paper

References (12)

1. Clements PJ, Hurwitz EL, Wong WK et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial. Arthritis Rheum 2000;43:2445-54.
2. Shand L, Lunt M, Nihtynova S et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis. Application of a latent linear trajectory model. Arthritis Rheum 2007;56:2422-31.
3. Khanna D, Merkel P. Outcome measures in systemic sclerosis: An update on instruments and current research. Curr Rheumatol Rep 2007;9:151-7.
4. Furst DE, Khanna D, Matucci-Cerinic M et al. Systemic sclerosis - continuing progess in developing clinical measures of response. J Rheumatol 2007;34: 1194-2000.
5. Clements PJ, Meedsger TA Jr, Feghali CA. Cutaneous involvement in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic sclerosis, 2nd edition. Lippincott Williams and Wilkins, 2004;129-50.
6. Furst DE, Clemens PJ, Steen VC et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998;25:84-8.
7. Verrechia F, Laboureau J, Verola O et al. Skin involvement in scleroderma - where histological and clinical scores meet. Rheumatology 2007;46:833-41.
8. Gazi H, Pope JE, Clements P et al. Outcome measurements in scleroderma: Results from a Delphi exercise. J Rheumatol 2007;34:501-9.
9. Czirják L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 2007;66:966-9.
10. Kissin EY, Schiller AM, Gelbard RB et al. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum 2006;55:603-9.
11. Merkel PA, Silliman NP, Denton CP et al. for the CAT-192 Research Group and the Scleroderma Clinical Trials Consortium. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum 2008;59:699-705.
12. Bendeck SE, Jacobe HT. Ultrasound as an outcome measure to assess disease activity in diorders of skin thickening: An example of the use of radiologic technique to assess skin disease (review). Dermatol Ther 2007;20:86-92.